SCHEMBL4826410

SCHEMBL4826410

CCN1C(=O)C(C)(C)c2cc3[nH]c(-c4n[nH]cc4NC(=O)c4cccs4)nc3cc21

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AURKA O14965 1/20 0.50
AURKB Q96GD4 1/20 0.50
STK33 Q9BYT3 10/20 0.42
MAPT P10636 6/20 0.41
POLB P06746 6/20 0.41
KMT2A Q03164 4/20 0.41
MEN1 O00255 3/20 0.41
MAPK1 P28482 2/20 0.41
TDP1 Q9NUW8 2/20 0.41
ALDH1A1 P00352 5/20 0.40
TP53 P04637 3/20 0.40
HPGD P15428 3/20 0.40
APAF1 O14727 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
HSD17B10 Q99714 2/20 0.40
KDM4E B2RXH2 2/20 0.40
PPARG P37231 1/20 0.40
RECQL P46063 1/20 0.40
SMAD3 P84022 1/20 0.40
PTK2B Q14289 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4825173 0.88 AURKA (0.51) AURKAAURKBMAPTPOLBKMT2A
SCHEMBL4825636 0.88 AURKA (0.52) AURKAAURKBSTK33MAPTKMT2A
SCHEMBL4829059 0.87 AURKA (0.53) AURKAAURKBSTK33MAPTKMT2A
SCHEMBL4823345 0.87 AURKA (0.52) AURKAAURKBMAPTALDH1A1TP53
SCHEMBL4829418 0.85 AURKA (0.58) AURKAAURKBMAPTPOLBKMT2A
SCHEMBL4829180 0.85 AURKA (0.51) AURKAAURKBSTK33MAPTPOLB
SCHEMBL4829419 0.85 AURKA (0.51) AURKAAURKBMAPTPOLBKMT2A
SCHEMBL4830762 0.85 AURKA (0.52) AURKAAURKBMAPTPOLBKMT2A
SCHEMBL4827459 0.85 AURKA (0.50) AURKAAURKBMAPTPOLBKMT2A
SCHEMBL4830784 0.85 AURKA (0.50) AURKAAURKBMAPTPOLBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060235065-A1 Aminopyrazole derivatives HOFFMANN-LA ROCHE INC. 2006-10-19 US claimed
US-7462639-B2 e.g 3-(7,7-Dimethyl-6-oxo-1,5,6,7-tetrahydro-imidazo[4,5-f]indol-2-yl)-1H-pyrazol-4-yl]-carbamic acid benzyl ester; Aurora A (serotonin/threonine) kinase inhibitors; anticarcinogenic agent; colorectal, breast, lung, prostate, pancreatic, gastric, bladder, ovarian cancer, melanoma, neuroblastoma HOFFMANN-LA ROCHE INC. (US) 2008-12-09 US disclosed
US-20060235065-A1 Aminopyrazole derivatives HOFFMANN-LA ROCHE INC. 2006-10-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060235065-A1 Aminopyrazole derivatives CYP3A43, CYP3A5, CYP3A4 AURKA 742/4885AURKB 1096/4885STK33 151/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.